ABSTRACT By differential display technique followed by RT-PCR and DNA sequence analyses, we isolated carcinoembryonic antigenrelated cell adhesion molecule 6 (Ceacam6) and its novel spliced variant Ceacam6-Long (Ceacam6-L) from rat testis. Ceacam6-L mRNA was generated by retention of 67 nucleotide-length third intron in Ceacam6 gene. Ceacam6-L is a member of an immunoglobulin superfamily and encodes a protein of 50 kDa with a signal sequence at the N-terminus, one immunoglobulin (Ig)-like domain, three IgCAM domains, a transmembrane region, and a short intracellular region. Expression analyses by RT-PCR and Northern blot showed that Ceacam6-L was exclusively expressed in rat testis and first detectable at 5 wk during postnatal development of testis. We performed immunoblot analyses and immunohistochemistry using the anti-CEA-CAM6-L antibody. Confocal laser scanning microscopy revealed that CEACAM6-L was not present at blood-testis barrier junctions between Sertoli cells but localized at the interface between Sertoli cells and germ cells, possibly to work as an adhesion molecule in the apical compartment of the seminiferous epithelium. At stages VII-VIII, at which all of the elongated spermatids migrated to the luminal surface of the seminiferous tubules, CEACAM6-L was found to locate at the concave side of elongated spermatid heads, following the curvature of their sickle-shaped nuclei, suggesting that CEACAM6-L might be involved in the anchoring of spermatids to Sertoli cells and spermiation. We concluded that CEACAM6-L might be a novel adhesion molecule constructing the apical ectoplasmic specialization in testis.
INTRODUCTION
Differentiation of germ cells in the testis is a complicated process, beginning with the proliferation of diploid spermatogonia and terminating with the production of haploid spermatozoa. During a postmeiotic stage, round haploid spermatids undergo the drastic morphological changes, such as acrosome formation, nuclear condensation, flagellum formation, mitochondrial sheath construction, and extrusion of residual cytoplasm [1, 2] , through which round spermatids are differentiated into mature spermatozoa. This tightly regulated process accompanying meiotic progression suggests the presence of a highly organized network of genes expressed during spermatogenesis. The regulation of gene expression during spermatogenesis is controlled three ways: intrinsically, interactively, and extrinsically [3] . The intrinsic program of gene expression determines which genes are expressed and when. Germ cells are always in close contact with somatic Sertoli cells during their differentiation, and this interactive process between germ cells and Sertoli cells seems to be involved in the regulation of gene expression that is required for proliferation and differentiation of spermatogenic cells. Extrinsic factors, such as cytokines/growth factors, steroid hormones, and peptide hormones released from Sertoli cells and/or interstitial cells, also have effects on germ cell differentiation.
In adult mammalian testes, tight junctions between Sertoli cells compose the blood-testis barrier (BTB), which divides the seminiferous epithelium (SEP) into two compartments: the basal compartment containing spermatogonia and the immuneprivileged adluminal (apical) compartment. Preleptotene spermatocytes translocate from the basal to the adluminal compartment for further maturation without compromising the integrity of the BTB [4, 5] . After traversing the BTB, spermatogenic cells rely on a series of transient junctions for anchorage onto Sertoli cells during their movement within the SEP. The ''ectoplasmic specializations'' (EPSs), testis-specific junctional structures formed by Sertoli cells, are composed of the plasma membrane, F-actin bundles, and an attached cistern of endoplasmic reticulum [6] . In the adluminal compartment of the SEP, assembly and disassembly of the EPSs are responsible for anchoring spermatids to Sertoli cells and sperm release into the lumen of the SEP, respectively. Many types of molecules, such as junctional adhesion molecules (JAMs), NECTINS, NECTIN-like molecules (NECLs), and coxsakie and adenovirus receptor (CAR), participate in the transient junctions, including the EPS via homophilic or heterophilic molecular interactions (see review by Cheng and Mruk [6] ).
To investigate the molecular mechanisms regulating the drastic morphological changes from round spermatids to spermatozoa, we employed a differential display technique in combination with cDNA cloning technique to isolate genes that start to be expressed at 3 or 4 wk of postnatal development in rat testis. By this approach, we have recently isolated many novel or unanalyzed genes that are expected to be involved in differentiation of spermatogenic cells [7] [8] [9] [10] [11] [12] . In this study, we reported on carcinoembryonic antigen-related cell adhesion molecule 6 (Ceacam6) and its novel spliced variant Ceacam6-Long (Ceacam6-L), which were isolated from rat testis by the same approach. Ceacam6-L is a member of an immunoglobulin (Ig) superfamily and encodes a protein with an Ig-like domain, three IgCAM domains, a transmembrane region, and a short intracellular domain, whereas Ceacam6 encodes a protein containing only one Ig-like domain without the transmembrane region. We present the data indicating that CEACAM6-L might work as one of the adhesion molecules building the apical EPS within the SEP.
MATERIALS AND METHODS

Animals
Animal experiments were approved by the Institutional Animal Care and Use Committee of Kyushu University. Investigations were conducted in accordance with the National Research Council publication Guide for Care and Use of Laboratory Animals. Animals for experiments were obtained from Kyudo Campany (Fukuoka, Japan).
Differential Display
The mRNA differential display was carried out using GeneFishing DEG Premix Kit (Seegene Inc., Rockville, MD). Briefly, total testis RNAs were isolated from Wistar rats ages 2 and 8 wk by QuickPrep Total RNA Extraction Kit (GE Healthcare BioScience Corp., Piscataway, NJ), as described previously [7, 8] . RNAs were reverse transcribed with oligo-(dT) primers anchored to the beginning of the poly(A) tail. The resulting cDNAs were amplified with oligo-(dT) primers and arbitrary primers. The PCR data shown in Figure 1 were obtained using dT-ACP2 and ACP-11 primers. The cycling parameters for PCR were as follows: 948C for 5 min, 508C for 3 min, and 728C for 1 min for one cycle, followed by 948C for 40 sec, 658C for 40 sec, and 728C for 40 sec for 40 cycles. The amplified cDNAs were separated on 1.5% agarose gels. The cDNA fragments, which were detected in 8-wk samples but not in 2-wk samples, were extracted from gels and reamplified using the same primers as the ones used in the initial PCR for differential display. The cDNA fragments were cloned into the pGEM easy T-vector (Promega, Madison, WI) for sequencing using a DNA sequencer (Applied Biosystems, Foster City, CA).
RNA Isolation, cDNA Synthesis, and RT-PCR Total RNAs were isolated from testis, epididymis, lung, kidney, intestine, stomach, brain, heart, liver, skeletal muscle, and spleen of 8-wk-old Wistar male rats. Total RNA was also isolated from testis of 1-to 8-wk-old rats. The cDNA strands were synthesized from 3 lg total RNA using a PrimeScript firststrand cDNA synthesis kit (Takara Biotech Co., Tokyo, Japan) with oligo-(dT) primer. The reverse transcribed cDNA was used as a PCR template to synthesize a gene. Polymerase chain reaction was performed using LA Taq DNA polymerase (Takara Biotech). Primers for glyceraldehyde-3-phosphate dehydrogenase (Gapdh) were 5 0 -TGA AGG TCG GTG TCA ACG GAT TTG GC-3 0 (forward) and 5 0 -CAT GTA GGC CAT GAG GTC CAC CAC-3 0 (reverse). The primers used to amplify an open reading frame of full-length Ceacam6 were 5 0 -ATG GAG CCC CCC TCA GCC CAT C-3 0 (forward) and 5 0 -ACT TAT GCT GAC CTG GTG GAT AGA C-3 0 (reverse). The primers used to amplify an open reading frame of full-length Ceacam6-L were 5 0 -ATG GAG CCC CCC TCA GCC CAT C-3 0 (forward) and 5 0 -GAA TCT TTT GTT CTA AGC CTT GTC AAG-3 0 (reverse). To amplify the C-terminal 821 base of Ceacam6-L, 5 0 -GAG TTG ATG ACC GCA TCG CCC TG-3 0 (forward) and 5 0 -GAA TCT TTT GTT CTA AGC CTT GTC AAG-3 0 (reverse) were used. The PCR-amplified DNA was cloned into pGEM-T easy vector (Promega) and sequenced using a DNA sequencer (Applied Biosystems).
Northern Blot Analysis
A Northern blot membrane loaded with 15 lg total RNA from 2-and 8-wkold rat testis was hybridized with the 858-base DNA (54-911 nucleotides; see Figure 3 ) that was obtained by PCR. The primers used to amplify the DNA fragment were 5 0 -GCT TGC AGC CTC ACT GCT AAC C-3 0 (forward) and 5 0 -GTT GCT GCG TTG TTG ACG AGG C-3 0 (reverse). The probe was purified by gel electrophoresis and labeled with DIG-dUTP, according to the instruction manual of Roche Molecular Biochemicals. Hybridization was performed as previously reported [7, 8] . The mRNA hybridized with the probe was immunologically detected by anti-DIG antibody conjugated with alkaline phosphatase, and then recorded on x-ray films with the chemiluminescence substrate CSPD (Roche Molecular Biochemicals). Ribosomal RNAs were visualized by staining the membrane with methylene blue.
Antibody Production
The antibody against CEACAM6-L was produced in rabbit against the amino acid sequence NH 3 -DDRIALSRDNAT-COOH of CEACAM6-L (see Figure 3 ), which is lacking in CEACAM6. The synthetic peptide was coupled with keyhole limpet hemocyanin (KLH; Sigma Chemical, St. Louis, MO), and the peptide coupled with KLH (1 mg total dose) was dissolved in 1 ml saline, emulsified with 1 ml Freund complete adjuvant, and injected at multiple sites on the back of a rabbit as described previously [7, 13] . The antiserum was collected within 2 wk after the third injection. Affinity purification of the antibody was carried out over a matrix of the peptide coupled with FormylCellulofine (Seikagaku Kogyo), as described previously [11, 12] . Preadsorbed antibody was made by incubation of the affinity-purified antibody with the synthetic peptide for 12 h at 48C, centrifuged for 30 min at 15 000 rpm, and resultant supernatant collected as adsorbed antibody.
Preparation of Glutathione S-Transferase-Fusion Proteins
Rat Ceacam6-L mRNA has an open reading frame of 1356 nucleotides encoding 452 amino acids. N-terminal 1-220 amino acids of CEACAM6-L were PCR amplified and cloned in frame to the COOH terminus of glutathione S-transferase (GST) using the pGEX-4T-1 system (GE Healthcare BioScience Corp.). Recombinant protein was expressed in Escherichia coli and purified onto glutathione-Sepharose (GE Healthcare BioScience), as previously described [11, 12] . Molecular mass of GST-CEACAM6-L is approximately 46 kDa. The GST-fused recombinant proteins rab3A, rab3D, rab6, spergen-3, spetex-2, iba1, spetex-1, and syntaxin 2 were similarly produced and purified. These recombinant proteins were used for immunoblot analysis.
Immunoblot Analysis
Testes of ether-anesthetized adult Wistar rats were immersed in PBS on ice, and capsule (tunica albuginea) was torn away by tweezers. Seminiferous tubules released from testes were untangled and washed for several washes in PBS at 48C with gentle agitation to remove interstitial cells. Spermatozoa, which were collected from the epididymis of adult rats, were purified by a Percoll density gradient centrifugation as reported previously [7, 13] . Both seminiferous tubules and purified spermatozoa were solubilized directly in an SDS-PAGE sample buffer, followed by centrifugation at 15 000 rpm for 20 min. Clarified supernatants were used as samples for SDS-PAGE and immunoblot analysis. The sample proteins prepared for SDS-PAGE were separated on 12% acrylamide gel, and separated proteins were either stained with Coomassie brilliant blue or transferred to nitrocellulose sheets. The sheets were incubated for 3 h with the affinity-purified anti-CEACAM6-L antibody diluted 1:5000 with a blocking buffer (PBS containing 5% nonfat milk and 0.05% Tween-20), followed by incubation with horseradish peroxidaseconjugated goat anti-rabbit IgG (Bio-Rad, Richmond, CA) diluted 1:2000 in the same buffer. Antigen-antibody complexes were visualized using an ECLPlus detection kit (GE Healthcare Bioscience). The GST-fused proteins were similarly processed for immunoblot analysis. RNA was reverse transcribed with oligo-(dT) primers. Resultant cDNAs were amplified with an oligo-(dT) primer (dT-ACP2 in the kit) and an arbitrary primer (ACP-11 in the kit). A cDNA differentially expressed (arrow) was recovered, eluted from gel, and reamplified. A PCR-amplified DNA fragment was sequenced by a DNA sequencer.
To prepare fractionated samples of seminiferous tubules, they were homogenized at 48C in 10 mM Tris-Cl buffer (pH 7.4) containing 0.25 M sucrose and protease inhibitor cocktail (Roche Diagnostics). The homogenates were then centrifuged for 20 min each at 1000 3 g, 10 000 3 g, and 100 000 3 g in turn to obtain pellets at each centrifugation. These pellets as well as the supernatant after 100 000 3 g centrifugation were processed for immunoblot analysis as described above.
Immunohistochemistry
Adult rat testes were fixed in 4% paraformaldehyde in PBS at 48C for 4 h, washed three times in PBS, incubated in PBS containing 50 mM NH 4 Cl for 30 min, then rinsed in PBS. After infiltration of 20% (w/v) sucrose in PBS, the testes were immersed in OCT compound (Tissue-Tek; Miles Inc., Elkhart, IN) and immediately frozen by liquid nitrogen. Frozen sections of 10-lm thickness were cut by a cryostat (CM1850; Leica, Nussloch, Germany). The sections were attached to poly-L-lysine-coated glass slides, then treated by autoclave for 5 min in 10 mM Tris-HCl (pH 8.3), the procedure that was essential for detection of the CEACAM6-L immunosignal. The sections were washed in PBS, exposed to 0.1% Triton X-100 in PBS, then double immunostained with the anti-CEACAM6-L antibody diluted 1:500 and monoclonal anti-tyrosine tubulin antibody (T9028; Sigma Chemical) diluted 1:1600, followed by incubation with goat anti-rabbit IgG conjugated with fluorescein isothiocyanate (GE Healthcare BioScience) and anti-mouse IgG conjugated with Cy3 (GE Healthcare BioScience). For nuclear staining, CEACAM6-L immunostained samples were incubated for 30 min with PBS containing SYTOX Orange (1:10 000 dilution; Molecular Probes, Eugene, OR). The samples were washed with PBS and examined by a confocal laser scanning microscope (Olympus LSM-GB 2000). For controls, the primary antibody was replaced by preimmune serum or the anti-CEACAM6-L antibody adsorbed with the synthetic peptide (adsorbed antibody) as described above.
Immunohistochemistry for Fragmented Materials
Fixed rat testes were decapsulated in PBS, and the seminiferous tubule was mass minced into small pieces. The pieces were transferred into a 10-ml tube containing 5 ml PBS. The material was gently passed through an 18-gauge needle and then a 21-gauge needle for two to five gentle passes. This fragmented material was left on ice to sediment by gravity for 5 min, and then the upper layer was transferred to another tube. The cells in suspension were pelleted by centrifugation, and the pellet was resuspended in a small volume of PBS. Cells in the suspension were attached to poly-L-lysine-coated glass slides. The slides were treated by autoclave for 5 min in 10 mM Tris-HCl (pH 8.3) before process for immunostaining, as described above.
Busulphan Treatment
Adult male Wistar rats (230-250 g) were injected intraperitoneally with two doses of busulphan (10 mg/kg of body weight; Sigma Chemical) 21 days apart. Busulphan was dissolved in dimethyl sulphoxide at a concentration of 2% immediately prior to use (the injected volume was 0.12-0.15 ml). Busulphaninjected rats were killed 14 days after the second injection, and their testes were removed and processed for immunoblot analysis and immunohistochemistry, as described above.
RESULTS
Isolation of Genes Developmentally Upregulated in Rat Testis
To obtain developmentally upregulated genes in rat testis, transcripts derived from testes of 2-and 8 wk-old rats were The third exon of the Ceacam6-L transcript is generated by retention of intron 3 (thick arrow) between exons 3 and 4 in the Ceacam6 gene. In both proteins, the first and second exons encode for the signal sequence and Ig-like domain, respectively. Ceacam6-L contains exons 3-5, each of which encodes for one Ig-CAM domain. Exon 6 of Ceacam6-L encodes for the transmembrane region. Neither Ig-CAM domain nor the transmembrane region is identified in CEACAM6. C) Sequence of 67-base-long intron 3, which is retained in Ceacam6-L (2) but removed from Ceacam6 (1), as well as the intron/exon boundary sequence are shown. The third intron in Ceacam6 starts with GT at 5 0 end and terminates with AG at 3 0 end.
1064 examined by differential display screening using 40 different combinations of primer pairs. One of the gene fragments, which was approximately 260 bp in length, was expressed at 8 wk of postnatal development but was not detected at 2 wk (Fig.  1) . The gene fragment was PCR amplified, ligated into T vector, and sequenced by a DNA sequencer. A search in National Center for Biotechnology Information (NCBI) and DNA Data Bank of Japan databases employing FASTA and BLAST programs revealed that the sequence of the fragmented gene exhibited a marked homology to the 3 0 untranslated region of Ceacam6 (accession number BC078962). A BLAST search against the rat genomic databases at NCBI uncovered that Ceacam6 was mapped as 10 exons at 1q21 of rat genome. Based on the sequence data of Ceacam6, we made primers for PCR, and we performed RT-PCR to obtain an open reading frame (798 bases) of Ceacam6 encoding a protein 266 amino acids in length. Unexpectedly, DNA analysis of the PCR products yielded two transcripts: one was identical to Ceacam6, and the other had an additional 67 nucleotides inserted between exons 3 and 4 of Ceacam6. Analysis of the genomic structure and the sequence of the Ceacam6 gene demonstrated that the sequence of 67 nucleotides was derived from the entire intron 3 between exons 3 and 4 ( Fig. 2A, thick  arrow) . Retention of the 67-nucleotide-long intron 3 in the transcript caused frame shift and resulted in the production of a novel spliced variant of Ceacam6, Ceacam6-L (accession number AB434131), in this study.
Genome and mRNA structures and the primary structures of encoded proteins of Ceacam6 and Ceacam6-L are schematically shown in Figure 2 . Protein structures were analyzed by SMART (http://smart.embl-heidelberg.de/), NCBI Conserved Domain Search (http://blast.ncbi.nlm.nih.gov/Blast.cgi), and SOSUI (http://bp.nuap.nagoya-u.ac.jp/sosui/). In Ceacam6 mRNA ( Fig. 2A) , the first and second exons encode for the   FIG. 3 . The coding sequence of Ceacam6-L and its deduced amino acid sequence. The signal sequence (dotted line), the transmembrane region (double lines), and 67 nucleotides (underline, 539-605 nucleotides) that is deleted as intron 3 from the Ceacam6 transcript, are highlighted. A polyclonal antibody was raised against the synthetic peptide (DDRIALSRDNAT) corresponding to 186-197 amino acid residues of CEACAM6-L (enclosed by a rectangle), which CEACAM6 lacks. Asterisk (*) represents the termination codon TAG.
signal sequence and Ig-like domain, respectively. The third, fourth, and fifth exons encode for the C-terminal region of CEACAM6. No transmembrane region is encoded in Ceacam6 mRNA. Since the termination codon is present in exon 5, the transcript has a relatively long 3 0 untranslated region (940 bases), including poly(A). The predicted molecular mass and isoelectric point (pI) of CEACAM6 are 30 kDa and 9.5, respectively.
In Ceacam6-L mRNA (Fig. 2B) , the first and second exons encode for the signal sequence and Ig-like domain, respectively. Exons 3-5 each encode for one Ig-CAM domain, and the transmembrane region is coded in exon 6. An open reading fame of Ceacam6-L is 1356 nucleotides in length encoding a protein of 452 amino acids in length, with 448 nucleotides at the 3 0 untranslated region. The predicted molecular mass and pI of CEACAM6-L are 50.9 kDa and 8.76, respectively.
To confirm that these two transcripts were expressed in rat testis, full-length Ceacam6-L coding region (1356 bases) was amplified by RT-PCR and sequenced which, as expected, resulted in production of two types of cDNA: one was identical to 1356-base-long Ceacam6-L, and the other was identical to the 798-base-long Ceacam6 lacking the 67-nucleotide-long intron 3. These two transcripts came into existence at an approximately 1:1 ratio in DNA sequence, suggesting that Ceacam6 and Ceacam6-L are equally transcribed in rat testis. The DNA sequence of the 67 bases that is removed from Ceacam6 as the intron 3 during splicing but is retained as a part of exon 3 in Ceacam6-L as well as intron/exon boundary sequences is shown in Figure 2C . Consistent with the RNA splicing rule [14] , the third intron in the Ceacam6 gene starts with GT at the 5 0 end and terminates with AG at the 3 0 end.
The intron retention brings about frame shift, which results in drastic change of the amino acid sequence. The coding sequence and deduced amino acid sequence for Ceacam6-L are shown in Fig. 3 , in which the N-terminal signal sequence, 12 amino acid residues (DDRIALSRDNAT) used for antibody production, and the transmembrane region are highlighted. The 67 nucleotides retained in Ceacam6-L are found in the middle region at 539-605 nucleotides of the gene. Comparing the amino acid sequences of CEACAM6 and CEACAM6-L elucidates that retention of intron 3 in Ceacam6-L mRNA brings about drastic change of amino acid sequences, by which only the N-terminal 180 amino acid residues are shared by the two molecules.
Expression Analyses
Lengths of both Ceacam6 and Ceacam6-L transcripts are supposed to be approximately 2.0 kb. To confirm their expression in rat testis, we performed Northern blot analysis. The N-terminal 858 nucleotides of Ceacam6-L were PCR amplified and used as a probe for Northern blot analysis. The probe hybridized to a transcript of approximately 2.0 kb on the blot, to which total RNA of 8-wk-old rat testes was transferred, whereas the probe created no signal on the blot of total RNA of 2-wk-old rat testis (Fig. 4A) . We next employed RT-PCR to examine both the developmental expression of Ceacam6-L in rat testes and the expression of the transcript in the various organs of adult rats. Primers were designed to amplify either the full length of both Ceacam6 and Ceacam6-L (Ceacam6/ Ceacam6-L, 1.3 kb) or the C-terminal 826 nucleotides of Ceacam6-L (Ceacam6-L/C, 0.8 kb). In the former case, both 
In the former case, both Ceacam6 and Ceacam6-L are amplified. In the latter case, the forward primer was set within the retention region so that the C-terminus of Ceacam6-L (826 nucleotides long, 530-1356 bases) is specifically amplified. C) The RT-PCR analysis was carried out to examine the expression levels of Ceacam6 and Ceacam6-L in testes of 1-to 8-wk-old rats. Both PCR products of 1.3-kb Ceacam6/Ceacam6-L and 0.8-kb Ceacam6-L/C were first detectable at 5 wk during the postnatal development of testis. The expression level of Gapdh appears to be constant throughout the developmental period. D) Expression of Ceacam6 and Ceacam6-L in various organs of adult rats. Both 1.3-kb Ceacam6/Ceacam6-L and 0.8-kb Ceacam6-L/C were highly expressed in testis but not detectable in other organs examined. The expression of Gapdh is displayed as a control for PCR amplification.
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Ceacam6 and Ceacam6-L were amplified. In the latter case, the forward primer (5 0 -GAGTTGATGACCGCATCGCCCTG-3 0 ) was set within the retention region so that the C-terminus of Ceacam6-L is specifically amplified (Fig. 4B) . As shown in Figure 4C , PCR products of both 1.3 and 0.8 kb were first detectable at 5 wk during postnatal development of testis, and high-level expressions were seen at 6-8 wk for 1.3-kb Ceacam6/Ceacam6-L and at 7-8 wk for 0.8-kb Ceacam6-L/C. Both PCR products of 1.3 and 0.8 kb were exclusively observed in testis but undetectable in other organs examined (Fig. 4D) .
Immunoblot Analyses of CEACAM6-L
To examine the expression and localization of CEACAM6-L protein in rat testis, a polyclonal antibody was raised against the synthetic peptide (DDRIALSRDNAT) corresponding to amino acid residues 186-197 of CEACAM6-L (Fig. 3) , the region CEACAM6 lacks. The anti-CEACAM6-L antibody was used after affinity purification. Specificity of the affinitypurified anti-CEACAM6-L antibody was first examined on the blot to which several GST-fused recombinant proteins were transferred. As shown in Figure 5A , the anti-CEACAM6-L antibody specifically recognized GST-CEACAM6-L but did not react with other GST-fusion proteins, indicating that the antibody is specific for CEACAM6-L.
To detect CEACAM6-L protein biochemically in testis, we performed immnunoblot analysis on the blots to which proteins extracted from rat SEP were transferred (Fig. 5B) . On the blot, the anti-CEACAM6-L antibody recognized a single band migrating at approximately 45-47 kDa in the sample. The size was smaller than the molecular mass of full-length of CEACAM6-L (50.9 kDa) calculated from the CEACAM6-L amino acid sequence deduced from the cDNA sequence. It might be due to removal of the signal sequence of 33 amino acid residues (molecular mass is 3561 Da) at the N-terminus of CEACAM6-L. CEACAM6-L protein was undetectable in the A CEACAM6 ISOFORM IN ECTOPLASMIC SPECIALIZATION 1067 sample prepared from purified spermatozoa (data not shown). Next, homogenates of rat seminiferous tubules were fractionated by centrifugation, and resultant samples were subjected to immunoblot analysis with the anti-CEACAM6-L antibody. A single band migrated at 45-47 kDa was detected in both the pellet obtained by 100 000 3 g centrifugation and its resultant supernatant (Fig. 5C ). The outcome suggested that CEA-CAM6-L might be present in the SEP as a membraneassociated protein and a cytosolic protein.
Confocal Laser Scanning Microscopy for CEACAM6-L
To localize CEACAM6-L within the SEP, sections of rat testis were processed for immunohistochemistry with the anti-CEACAM6-L antibody using a confocal laser scanning microscope. Since immunoreactive products for CEACAM6-L were detected within Sertoli cells (Fig. 6A) , the anti-tyrosine tubulin antibody that specifically labeled Sertoli cells was used in combination with the anti-CEACAM6-L antibody. Control sections stained with preimmune serum or adsorbed anti-CEACAM6-L antibody did not produce any specific immunolabeling in the SEP (Fig. 6B) . It has been well known that the shape of Sertoli cells showed distinct cyclic changes during the SEP cycle [15] . Stages of the SEP were inferred from morphologies of immunostained Sertoli cells in conjugation with nuclear DNA staining by SYTOX Orange.
Differences in the distribution of immunostained CEA-CAM6-L within the SEP were observed at different stages of the SEP cycles. At stages I-III (Fig. 6C) , linear immunolabeled CEACAM6-L was observed apical to basal in a track parallel to the long axis of Sertoli cells. Colocalization of tyrosinetubulin and CEACAM6-L suggested the presence of CEA-CAM6-L in the Sertoli cells. In addition, immunostaining for CEACAM6-L not only produced specklelike immunoproducts in germ cells (Fig. 6C) , but also brought about diffuse labeling in the cytoplasm of elongated spermatids (Fig. 6D) . At stages IV-V, at which elongated spermatids were deeply embedded in the Sertoli cytoplasm, the immunostaining pattern for CEA-CAM6-L was almost the same as that in stages I-III (Fig. 6E) ; the anti-CEACAM6-L antibody labeled Sertoli cells, spermatid cytoplasm, and specklelike organelle in germ cells within the SEP. At stages VII-VIII, at which all of the elongated spermatids migrated to the luminal surface of the SEP, crescentlike immunolabelings that were encompassed by Sertoli cell cytoplasm were highlighted at the luminal part of the SEP (Fig. 6F) . Although specklelike immunoproducts were still seen within the SEP, the intensity of linear immunostaining for CEACAM6-L was reduced (Fig. 6F) . Just after spermiation (stage IX), CEACAM6-L immunostaining was seen mainly in the residual bodies located at the luminal part of the SEP (Fig.  6G) . We did not detect any CEACAM6-L immunolabeling on spermatozoa released into the lumen of the seminiferous tubules. At stages X-XII, where Sertoli cells were less prominent compared with I-VIII stages, CEACAM6-L immunolabeling was seen in undeveloped Sertoli cells and specklelike structures within the SEP (Fig. 6, A and H) .
To elucidate the positional relationship between the localizations of CEACAM6-L and spermatogenic cell nuclei, we examined by confocal laser scanning microscopy the samples immunostained with the anti-CEACAM6-L antibody, followed by counterstaining with SYTOX Orange, which stains nuclear DNA. Specklelike structures immunolabeled by the anti-CEACAM6-L antibody were seen close to nuclei of both spermatocytes and round spermatids (Fig. 7, A and B) . Linear tract of immunolabeled CEACAM6-L was associated with nuclei of elongated spermatids (Fig. 7B) . Crescentlike immunolabeling, which was seen at the luminal part of the SEP in stages VII-VIII, was visible at the concave side of elongated spermatid heads, following the curvature of their sickle-shaped nuclei (Fig. 7C) .
We next examined the localization of CEACAM6-L in spermatids isolated from fixed testis by mechanical fragmentation, the procedure that yielded spermatids associated with Sertoli cytoplasm (Fig. 8A) . Confocal laser scanning microscopy clearly revealed that CEACAM6-L was present along the curvature of the sickle-shaped nuclei in step 17-19 spermatids (Fig. 8B) or seen at the region on the border of the cytoplasm of Sertoli cells (Fig. 8C) . In more premature spermatids (steps 10-13), a large part of condensing nuclei was encompassed by CEACAM6-L immunolabeling (Fig. 8D ).
Busulphan Treatment
As described in the Introduction, the interactive process between germ cells and Sertoli cells might be a step for controlling gene expression during spermatogenesis. To examine whether expression of CEACAM6-L in Sertoli cells is germ cell dependent, we performed immunohistochemistry on busulphan-treated testis. Busulphan treatment led to destructive changes in the structure of the SEP, yielding degenerate tubules consisting of Sertoli cells with a few spermatogenic cells (Fig. 9A) . As shown in Figure 9B , Sertoli cells revealed strong immunosignals for CEACAM6-L, in spite of a loss of nearly all germ cells. In addition, immunoblot analysis showed that busulphan treatment had little effect on CEACAM6-L expression in the SEP (Fig. 9C) . The observation suggested that CEACAM6-L expression in Sertoli cells is not affected by the interactive process between germ cells and Sertoli cells.
DISCUSSION
Carcinoembryonic antigen (CEA), an important tumor marker in the clinical management of human malignancies, is frequently found to be overexpressed in a wide variety of carcinomas at many sites, including colon, breast, and lung [16, 17] . All CEA family members tested have been shown to function as intercellular adhesion molecules [17] . The CEA family represents a subfamily of the immunoglobulin super- family and is divided into two subclasses: the CEA-related cell adhesion molecule (CEACAM) and the pregnancy-specific glycoprotein [18] . The CEACAM subclass can be subdivided into three distinct groups based on linkage to the plasma membrane. The numbers 1-4 (CEACAMs 1-4) were assigned to genes encoding proteins with transmembrane domains. The numbers 5-8 (CEACAMs 5-8) were assigned to genes encoding glycophosphatidyl inositol (GPI)-anchored proteins, and the numbers 9-11 (CEACAMs 9-11) were assigned to the remaining genes encoding secretory proteins [18, 19] . Of CEACAM members, CEACAM1 has been reported to be involved in adhesive interactions between Sertoli cells and differentiating germ cells [20] , and CEACAM2 was found to be expressed in mouse testis [21] .
CEACAM6 is a set of GPI-anchored, intercellular adhesion molecules and is upregulated in a wide variety of human cancers, including colon, breast, and lung [22] [23] [24] . It has been reported that CEACAM6 could mediate its tumorigenic effects through perturbation of integrin a 5 b 1 -fibronectin interaction [25] . In this study, we isolated Ceacam6 by differential display followed by RT-PCR, and we identified Ceacam6-L as a novel spliced variant of Ceacam6. CEACAM6-L, which is different from CEACAM6 in that it has three IgCAM domains and the transmembrane region, is generated by retention of intron 3 (67 nucleotides in length) in the Ceacam6 gene. Intron retention in the Ceacam6-L transcript brought about frame shift and resultant drastic change of amino acid sequence, by which only N-terminal 180 amino acid residues were shared by the two molecules. Although the detailed mechanism for intron retention is not fully understood, it is generally thought that a higher frequency of intron retention is associated with genes possessing introns shorter than exons and individual introns that have weaker splice sites [26] . The total length of the retained intron 3 and flanking exons is 279 bases in the Ceacam6 gene. It is probable that the 67-nucleotide intron 3 of the Ceacam6 gene is part of longer units that are at times recognized as a single long exon and at times as split exon þ intron þ exon structures in rat testis.
The processes of spermatogenesis within the SEP are highly dependent on specific interactions between Sertoli cells and developing germ cells at critical times during gametogenesis. Sertoli cells maintain two types of specialized cell-cell junctions, termed EPSs. Basal EPSs form between Sertoli cells near the base of the epithelium, whereas apical EPSs form between Sertoli cells and the heads of elongated spermatids [5, 27, 28] . Apical EPSs are responsible not only for linking the spermatid to the Sertoli cell but also for the translocation of spermatids through the SEP and their timely release into the lumen. In rat Sertoli cells, EPS starts to appear when neighboring germ cells become step 8 round spermatids, and it disappears prior to the release of mature step19 spermatids [4] . Many types of molecules have been reported to play a role as adhesion molecules at the Sertoli cell-spermatid interface in the adluminal compartment. PVRL2 (also known as NECTIN-2) on Sertoli cells and PVRL3 (also known as NECTIN-3) on spermatids form trans-heterotypic junctional complexes. In the absence of PVRL2 or PVRL3, EPS at Sertoli cell-spermatid junctions does not form properly, which results in exhibition of defective sperm morphogenesis and male infertility [29] [30] [31] . In testis of Cadm1 (also known as NECL-2)-deficient mice, round and elongating spermatids failed to attach to the Sertoli cells and were sloughed off into the tubule lumen, resulting in male infertility [32] [33] [34] [35] . Heterophilic interaction between PVR (also known as NECL-5) on Sertoli cells and CADM1 expressed on germ cells [36] may explain the indispensable role of CADM1 in spermatogenesis. JAM2 (also known as JAM-B) on Sertoli cells and JAM3 (also known as JAM-C) on the spermatids form heterotypic interactions. JAM3 plays an essential role for spermatogenesis because of a lack of mature spermatozoa in JAM3 knockout mice [37] . Trans-homophilic CAR-CAR interactions between spermatogenic cells and Sertoli cells might contribute to anchoring of germ cells to Sertoli cells and allowance of germ cell passage through the SEP [38] . Thus, several molecules constructing junctions between Sertoli and germ cells should play essential roles for spermatogenesis.
Both RT-PCR and Northern blot analyses revealed that Ceacam6-L is exclusively expressed in testis, and its expression was developmentally upregulated in testis. It was first detectable at 5 wk of postnatal development, at which point haploid elongated spermatids start to appear within the SEP. Immunoblot analyses showed that CEACAM6-L might be present as a membrane-associated protein and a cytosolic protein in the SEP. Immunohistochemical data showed that CEACAM6-L is not present at BTB junction formed between Sertoli cells, but localized at the interface between Sertoli cells and spermatids to possibly work as an adhesion molecule in the apical compartment of the SEP. At spermatids at steps 17-18, confocal laser scanning microscopy strongly suggested that CEACAM6-L was strictly localized at the anterior concave side of elongated spermatid heads, following the curvature of their sickle-shaped nuclei, suggesting that CEACAM6-L might be involved in anchoring spermatids to Sertoli cells. In view of the fact that CEACAM6-L is a member of the immunoglobulin superfamily, these data allowed us to suppose that CEACAM6-L might be a novel adhesion molecule constructing the apical EPS.
There is a possibility that CEACAM6-L plays some roles for spermiation, the final step of spermatogenesis whereby elongated spermatids are liberated from Sertoli cells and release into the seminiferous tubule lumen. Spermiation process is morphologically divided into several steps, commencing at the beginning of stage VII and ending during stage VIII (see Russell [39] for review). Disassembly and removal of the apical EPS are essential steps for spermiation. In step 18 and 19 spermatids, CEACAM6-L was observed along the inner ventral curvature of sickle-shaped nuclei of spermatids in which Tubulobulbar complexes (TBCs) are formed. Tubulobulbar complexes are composed of several tubular invaginations formed at the plasma membrane of Sertoli cells, and they are transiently formed at the contact region with spermatids at stage VII in rats. Tubulobulbar complexes seem to be involved in the disassembly of EPS by internalizing the intercellular membrane adhesion domains during sperm release [40] [41] [42] . Since the immunostaining pattern of CEACAM6-L at the concave side of spermatids (Fig. 8B) is different from those of TBC-associated molecules, such as amphiphysin1, dynamin2, and actin [43] , it is unlikely that CEACAM6-L is directly associated with the tubular membrane of TBCs and involved in TBC-related EPS disassembly.
Transmembrane proteins of the immunoglobulin superfamily have been known to confer adhesion between Sertoli and germ cells via either heterotypical interactions or homotypical interactions. PVRL2 and PVRL3 [44] , JAM2 and JAM3 [37] , as well as CADM1 and PVR [36] form heterotypical complexes, whereas CAR localized at both the BTB and EPS [38] might work as an adhesion molecule via a homotypical interaction. It is important to determine whether CEACAM6-L forms a heterotypical complex or a homotypical complex in the SEP. It is certain that CEACAM6-L was expressed in Sertoli cells in rat testis. Expression of CEACAM6-L in Sertoli cells seems to be germ cell independent, because CEACAM6-L was detected in the Sertoli cells of busulfan-treated testis in which a A CEACAM6 ISOFORM IN ECTOPLASMIC SPECIALIZATION large part of spermatogenic cells were lost. Immunosignals for CEACAM6-L also appeared as diffuse staining in the spermatid cytoplasm (Fig. 6D) as well as specklelike spots in spermatocytes and spermatids (Fig. 6 , A, C, and F). These observations raise the possibility that CEACAM6-L was expressed in germ cells as well. To examine this presumption, we intended to purify spermatogenic cells by the method of Koga et al. [45] to perform Western blot analysis. However, immunoblot analysis using antibodies against the marker proteins for Sertoli cells revealed that the germ cell fraction obtained by the method was contaminated by Sertoli cells, which interfered with our intention. It is, therefore, remained to determine whether CEACAM6-L is expressed in spermatogenic cells.
In conclusion, we have cloned a novel spliced variant Ceacam6-L from rat testis, which was generated by retention of a 67-nucleotide-long intron 3 in the Ceacam6 gene. Ceacam6-L was exclusively expressed in rat testis, and its expression was developmentally upregulated. Confocal laser scanning microscopy revealed that CEACAM6-L was not present at BTB junctions between Sertoli cells but localized at the interface between Sertoli cells and germ cells, suggesting that CEA-CAM6-L might be a novel adhesion molecule constructing the apical EPS in testis.
